2025-2031 Global Livestock mRNA Vaccines Industry Research & Trends Analysis Report

2025-2031 Global Livestock mRNA Vaccines Industry Research & Trends Analysis Report

  • Publication Date: 2025-03-14
  • Report Id: 1968152
  • Industry: Pharma & Healthcare
  • Report Page: 139
  • Chart: 139
sample
customized
pdf

PDF Download

  • Publication Date: 2025-03-14
  • Report Id: 1968152
  • Industry: Pharma & Healthcare
  • Report Page: 139
  • Chart: 139
sample
customized
pdf

PDF Download

  • Table of Contents
  • Description
  • Table of Figures
  • Need a Quote? quote

1 Market Overview
1.1 Livestock mRNA Vaccines Definition
1.2 Global Livestock mRNA Vaccines Market Size and Forecast
1.2.1 By Revenue, Global Livestock mRNA Vaccines Market Size, 2020-2031
1.2.2 By Sales Volume, Global Livestock mRNA Vaccines Market Size, 2020-2031
1.2.3 Global Livestock mRNA Vaccines Price Trend, 2020-2031
1.3 China Livestock mRNA Vaccines Market Size and Forecast
1.3.1 By Revenue, China Livestock mRNA Vaccines Market Size, 2020-2031
1.3.2 By Sales Volume, China Livestock mRNA Vaccines Market Size, 2020-2031
1.3.3 China Livestock mRNA Vaccines Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Livestock mRNA Vaccines Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Livestock mRNA Vaccines Share in Global Market, 2020-2031
1.4.3 Livestock mRNA Vaccines Market Size: China VS Global, 2020-2031
1.5 Livestock mRNA Vaccines Market Dynamics
1.5.1 Livestock mRNA Vaccines Market Drivers
1.5.2 Livestock mRNA Vaccines Market Restraints
1.5.3 Livestock mRNA Vaccines Industry Trends
1.5.4 Livestock mRNA Vaccines Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Livestock mRNA Vaccines Revenue by Company, 2020-2025
2.2 Global Livestock mRNA Vaccines Sales Volume by Company, 2020-2025
2.3 Global Livestock mRNA Vaccines Price by Company, 2020-2025
2.4 Global Livestock mRNA Vaccines Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Livestock mRNA Vaccines Concentration Ratio
2.6 Global Livestock mRNA Vaccines Mergers & Acquisitions, Expansion Plans
2.7 Global Livestock mRNA Vaccines Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Livestock mRNA Vaccines Revenue by Company, 2020-2025
3.2 China Livestock mRNA Vaccines Sales Volume by Company, 2020-2025
3.3 China Livestock mRNA Vaccines Livestock mRNA Vaccines Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Livestock mRNA Vaccines Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Livestock mRNA Vaccines Domestic VS Export
3.6 China Market, Livestock mRNA Vaccines Import & Export
3.6.1 China Market, Livestock mRNA Vaccines Import & Export, 2020-2031
3.6.2 China Livestock mRNA Vaccines Import & Export Trends
3.6.3 Main Sources of China Livestock mRNA Vaccines Import
3.6.4 Export Destination of China Livestock mRNA Vaccines

4 Livestock mRNA Vaccines Production by Region
4.1 Global Livestock mRNA Vaccines Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Livestock mRNA Vaccines Manufacturers
4.3 Global Major Manufacturers, Livestock mRNA Vaccines Capacity Expansion and Future Plans
4.4 Global Livestock mRNA Vaccines Capacity by Region
4.5 Global Livestock mRNA Vaccines Production by Region
4.5.1 Global Livestock mRNA Vaccines Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Livestock mRNA Vaccines Production by Region, 2020-2025
4.5.3 Global Livestock mRNA Vaccines Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Livestock mRNA Vaccines Industry Chain
5.2 Livestock mRNA Vaccines Upstream Analysis
5.2.1 Livestock mRNA Vaccines Core Raw Materials
5.2.2 Main Manufacturers of Livestock mRNA Vaccines Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Livestock mRNA Vaccines Production Mode
5.6 Livestock mRNA Vaccines Procurement Model
5.7 Livestock mRNA Vaccines Industry Sales Model and Sales Channels
5.7.1 Livestock mRNA Vaccines Sales Model
5.7.2 Livestock mRNA Vaccines Typical Distributors

6 Sights by Product Type
6.1 Livestock mRNA Vaccines Classification
6.1.1 Injectable Drug Administration
6.1.2 Non-invasive Drug Administration
6.2 by Type, Global Livestock mRNA Vaccines Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Livestock mRNA Vaccines Revenue, 2020-2031
6.4 by Type, Global Livestock mRNA Vaccines Sales Volume, 2020-2031
6.5 by Type, Global Livestock mRNA Vaccines Price, 2020-2031

7 Sights by Application
7.1 Livestock mRNA Vaccines Segment by Application
7.1.1 Cattle
7.1.2 Pigs
7.1.3 Others
7.2 by Application, Global Livestock mRNA Vaccines Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Livestock mRNA Vaccines Revenue, 2020-2031
7.4 by Application, Global Livestock mRNA Vaccines Sales Volume, 2020-2031
7.5 by Application, Global Livestock mRNA Vaccines Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Livestock mRNA Vaccines Market Size, 2020 VS 2024 VS 2031
8.2 By Region, Global Livestock mRNA Vaccines Revenue, 2020-2031
8.3 By Region, Global Livestock mRNA Vaccines Sales Volume, 2020-2031
8.4 North America
8.4.1 North America Livestock mRNA Vaccines Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Livestock mRNA Vaccines Market Size Market Share
8.5 Europe
8.5.1 Europe Livestock mRNA Vaccines Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Livestock mRNA Vaccines Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Livestock mRNA Vaccines Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Livestock mRNA Vaccines Market Size Market Share
8.7 South America
8.7.1 South AmericaLivestock mRNA Vaccines Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Livestock mRNA Vaccines Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Livestock mRNA Vaccines Market Size & CAGR,2020 VS 2024 VS 2031
9.2 By Country, Global Livestock mRNA Vaccines Revenue, 2020-2031
9.3 By Country, Global Livestock mRNA Vaccines Sales Volume, 2020-2031
9.4 United States
9.4.1 United States Livestock mRNA Vaccines Market Size, 2020-2031
9.4.2 By Company, United States Livestock mRNA Vaccines Sales Volume Market Share, 2024
9.4.3 by Type, United States Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.4.4 by Application, United States Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Livestock mRNA Vaccines Market Size, 2020-2031
9.5.2 By Company, Europe Livestock mRNA Vaccines Sales Volume Market Share, 2024
9.5.3 by Type, Europe Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.5.4 by Application, Europe Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.6 China
9.6.1 China Livestock mRNA Vaccines Market Size, 2020-2031
9.6.2 By Company, China Livestock mRNA Vaccines Sales Volume Market Share, 2024
9.6.3 by Type, China Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.6.4 by Application, China Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Livestock mRNA Vaccines Market Size, 2020-2031
9.7.2 By Company, Japan Livestock mRNA Vaccines Market Share, 2024
9.7.3 by Type, Japan Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.7.4 by Application, Japan Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Livestock mRNA Vaccines Market Size, 2020-2031
9.8.2 By Company, South Korea Livestock mRNA Vaccines Market Share, 2024
9.8.3 by Type, South Korea Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.8.4 by Application, South Korea Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Livestock mRNA Vaccines Market Size, 2020-2031
9.9.2 By Company, Southeast Asia Livestock mRNA Vaccines Market Share, 2024
9.9.3 by Type, Southeast Asia Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.9.4 by Application, Southeast Asia Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.10 India
9.10.1 India Livestock mRNA Vaccines Market Size, 2020-2031
9.10.2 By Company, India Livestock mRNA Vaccines Market Share, 2024
9.10.3 by Type, India Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.10.4 by Application, India Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Livestock mRNA Vaccines Market Size, 2020-2031
9.11.2 By Company, Middle East & Africa Livestock mRNA Vaccines Market Share, 2024
9.11.3 by Type, Middle East & Africa Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031
9.11.4 by Application, Middle East & Africa Livestock mRNA Vaccines Market Size, Share, 2024 VS 2031

10 Manufacturers Profile
10.1 Ceva Animal Health
10.1.1 Ceva Animal Health Company Information, Head Office, Market Area, and Industry Position
10.1.2 Ceva Animal Health Livestock mRNA Vaccines Models, Specifications, and Application
10.1.3 Ceva Animal Health Livestock mRNA Vaccines Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Ceva Animal Health Company Profile and Main Business
10.1.5 Ceva Animal Health Recent Developments
10.2 Merck Animal Health
10.2.1 Merck Animal Health Company Information, Head Office, Market Area, and Industry Position
10.2.2 Merck Animal Health Livestock mRNA Vaccines Models, Specifications, and Application
10.2.3 Merck Animal Health Livestock mRNA Vaccines Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Merck Animal Health Company Profile and Main Business
10.2.5 Merck Animal Health Recent Developments
10.3 Areterna
10.3.1 Areterna Company Information, Head Office, Market Area, and Industry Position
10.3.2 Areterna Livestock mRNA Vaccines Models, Specifications, and Application
10.3.3 Areterna Livestock mRNA Vaccines Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Areterna Company Profile and Main Business
10.3.5 Areterna Recent Developments
10.4 Bayer
10.4.1 Bayer Company Information, Head Office, Market Area, and Industry Position
10.4.2 Bayer Livestock mRNA Vaccines Models, Specifications, and Application
10.4.3 Bayer Livestock mRNA Vaccines Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.4.4 Bayer Company Profile and Main Business
10.4.5 Bayer Recent Developments
10.5 BioNTech
10.5.1 BioNTech Company Information, Head Office, Market Area, and Industry Position
10.5.2 BioNTech Livestock mRNA Vaccines Models, Specifications, and Application
10.5.3 BioNTech Livestock mRNA Vaccines Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.5.4 BioNTech Company Profile and Main Business
10.5.5 BioNTech Recent Developments
10.6 Genvax Technologies
10.6.1 Genvax Technologies Company Information, Head Office, Market Area, and Industry Position
10.6.2 Genvax Technologies Livestock mRNA Vaccines Models, Specifications, and Application
10.6.3 Genvax Technologies Livestock mRNA Vaccines Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.6.4 Genvax Technologies Company Profile and Main Business
10.6.5 Genvax Technologies Recent Developments
10.7 BioVenic
10.7.1 BioVenic Company Information, Head Office, Market Area, and Industry Position
10.7.2 BioVenic Livestock mRNA Vaccines Models, Specifications, and Application
10.7.3 BioVenic Livestock mRNA Vaccines Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.7.4 BioVenic Company Profile and Main Business
10.7.5 BioVenic Recent Developments
10.8 Moderna
10.8.1 Moderna Company Information, Head Office, Market Area, and Industry Position
10.8.2 Moderna Livestock mRNA Vaccines Models, Specifications, and Application
10.8.3 Moderna Livestock mRNA Vaccines Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.8.4 Moderna Company Profile and Main Business
10.8.5 Moderna Recent Developments
10.9 Ruipu Biotechnology
10.9.1 Ruipu Biotechnology Company Information, Head Office, Market Area, and Industry Position
10.9.2 Ruipu Biotechnology Livestock mRNA Vaccines Models, Specifications, and Application
10.9.3 Ruipu Biotechnology Livestock mRNA Vaccines Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.9.4 Ruipu Biotechnology Company Profile and Main Business
10.9.5 Ruipu Biotechnology Recent Developments
10.10 Jinyu Bio-technology
10.10.1 Jinyu Bio-technology Company Information, Head Office, Market Area, and Industry Position
10.10.2 Jinyu Bio-technology Livestock mRNA Vaccines Models, Specifications, and Application
10.10.3 Jinyu Bio-technology Livestock mRNA Vaccines Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.10.4 Jinyu Bio-technology Company Profile and Main Business
10.10.5 Jinyu Bio-technology Recent Developments
10.11 Shanghai Shen Lian Biomedical
10.11.1 Shanghai Shen Lian Biomedical Company Information, Head Office, Market Area, and Industry Position
10.11.2 Shanghai Shen Lian Biomedical Livestock mRNA Vaccines Models, Specifications, and Application
10.11.3 Shanghai Shen Lian Biomedical Livestock mRNA Vaccines Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.11.4 Shanghai Shen Lian Biomedical Company Profile and Main Business
10.11.5 Shanghai Shen Lian Biomedical Recent Developments
10.12 Suzhou Kerui Meide Biomedical Technology
10.12.1 Suzhou Kerui Meide Biomedical Technology Company Information, Head Office, Market Area, and Industry Position
10.12.2 Suzhou Kerui Meide Biomedical Technology Livestock mRNA Vaccines Models, Specifications, and Application
10.12.3 Suzhou Kerui Meide Biomedical Technology Livestock mRNA Vaccines Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.12.4 Suzhou Kerui Meide Biomedical Technology Company Profile and Main Business
10.12.5 Suzhou Kerui Meide Biomedical Technology Recent Developments
10.13 Shanghai Rnacure Biopharma
10.13.1 Shanghai Rnacure Biopharma Company Information, Head Office, Market Area, and Industry Position
10.13.2 Shanghai Rnacure Biopharma Livestock mRNA Vaccines Models, Specifications, and Application
10.13.3 Shanghai Rnacure Biopharma Livestock mRNA Vaccines Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.13.4 Shanghai Rnacure Biopharma Company Profile and Main Business
10.13.5 Shanghai Rnacure Biopharma Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer